{
    "2015-02-04": [
        "Gilead Q4 Earnings Beat, But Price War Taking Toll",
        "#IBDNews via @IBDinvestors",
        "$GILD $ABBV $ESRX $CTRX",
        "@matthewherper $ABBV was not the one to price a mass market drug exorbitantly using outdated SoC for justification",
        "BMO $GILD $ABBV $ENTA The Price War Hep-C Between Will Have a Significant and Lasting Impact (The Winner: Patients!)",
        "$DIA Stock Message Board Updated Wednesday, February 4, 2015 01:03:24 AM",
        "$CMG $MIDU $CELG $ABBV",
        "$GILD - 4 th - QTR profit quadruples 3.84 Billion in hep C drug sales"
    ]
}